|
"ann lii cheng"的相關文件
顯示項目 581-630 / 690 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T15:18:39Z |
Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma
|
Hsu, Chih-Hung; Cheng, Ann-Lii; Yeh, Kun-Huei; Wang, Hsiu-Po; Cheng, Jason Chia-Hsien; Lee, Jang-Ming; Huang, Pei-Ming; Chang, Chin-Hao; Hsieh, Min-Shu; PEI-MING HUANG; Lin, Chia-Chi; ANN-LII CHENG; JANG-MING LEE; Guo, Jhe-Cyuan;Huang, Ta-Chen;Lin, Chia-Chi;Hsieh, Min-Shu;Chang, Chin-Hao;Huang, Pei-Ming;Lee, Jang-Ming;Hsu, Feng-Ming;Cheng, Jason Chia-Hsien;Wang, Hsiu-Po;Yeh, Kun-Huei;Cheng, Ann-Lii;Hsu, Chih-Hung; Guo, J.-C. and Huang, T.-C. and Lin, C.-C. and Hsieh, M.-S. and Chang, C.-H. and Huang, P.-M. and Lee, J.-M. and Hsu, F.-M. and Cheng, J.C.-H. and Wang, H.-P. and Yeh, K.-H. and Cheng, A.-L. and Hsu, C.-H.; 林家齊;鄭安理;成佳憲;黃大成;徐志宏;葉坤輝;謝明書;郭哲銓;李章銘;王秀伯;黃培銘;許峰銘;張晉豪; MIN-SHU HSIEH; Guo, Jhe-Cyuan; Huang, Ta-Chen; Hsu, Feng-Ming |
| 臺大學術典藏 |
2018-09-10T15:18:35Z |
Consensus Development from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014).
|
Hsu, Chiun;Chen, Bang-Bin;Chen, Chien-Hung;Ho, Ming-Chih;Cheng, Jason Chia-Hsien;Kokudo, Norihiro;Murakami, Takamichi;Yeo, Winnie;Seong, Jinsil;Jia, Ji-Dong;Han, Kwan-Hyub;Cheng, Ann-Lii; 鄭安理;成佳憲;陳邦斌;許駿;陳健弘;何明志; Hsu, Chiun; MING-CHIH HO; Hsu, Chiun; Chen, Bang-Bin; Chen, Bang-Bin; BANG-BIN CHEN; Wu, Chien-Te; Libertus, Melissa E.; ANN-LII CHENG; Chen, Chien-Hung; Chen, Chien-Hung; Meyerhoff, Karen L.; Ho, Ming-Chih; Ho, Ming-Chih; Cheng, Jason Chia-Hsien; Woldorff, Marty G.; Kokudo, Norihiro; Kokudo, Norihiro; Murakami, Takamichi; Murakami, Takamichi; Yeo, Winnie; Seong, Jinsil; Seong, Jinsil; Jia, Ji-Dong; Han, Kwan-Hyub; Cheng, Ann-Lii; 吳建德; 成佳憲 |
| 臺大學術典藏 |
2018-09-10T15:17:40Z |
Phase i study of nanoliposomal irinotecan (PEP02) in advanced solid tumor patients
|
Chang, T.C. and Shiah, H.S. and Yang, C.H. and Yeh, K.H. and Cheng, A.L. and Shen, B.N. and Wang, Y.W. and Yeh, C.G. and Chiang, N.J. and Chang, J.Y. and Chen, L.T.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T15:17:38Z |
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
|
Chen, Wei-Wu; Chen, I-Chun; Wu, Pei-Fang; Wu, Pei-Fang; Kuo, Sung-Hsin; Kuo, Sung-Hsin; Chen, Chien-Jen; Chen, Chien-Jen; Lu, Yen-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; Lin, Ching-Hung;Shen, Chen-Yang;Lee, Jih-Hsiang;Huang, Chiun-Sheng;Yang, Chih-Hsin;Kuo, Wen-Hung;Chang, Dwan-Ying;Hsiung, Chia-Ni;Kuo, Kuan-Ting;Chen, Wei-Wu;Chen, I-Chun;Wu, Pei-Fang;Kuo, Sung-Hsin;Chen, Chien-Jen;Lu, Yen-Shen;Cheng, Ann-Lii; Lin, Ching-Hung;Shen, Chen-Yang;Lee, Jih-Hsiang;Huang, Chiun-Sheng;Yang, Chih-Hsin;Kuo, Wen-Hung;Chang, Dwan-Ying;Hsiung, Chia-Ni;Kuo, Kuan-Ting;Chen, Wei-Wu;Chen, I-Chun;Wu, Pei-Fang;Kuo, Sung-Hsin;Chen, Chien-Jen;Lu, Yen-Shen;Cheng, Ann-Lii; Ching-Hung Lin and Chen-Yang Shen and Jih-Hsiang Lee and Chiun-Sheng Huang and Chih-Hsin Yang and Wen-Hung Kuo and Dwan-Ying Chang and Chia-Ni Hsiung and Kuan-Ting Kuo and Wei-Wu Chen and I-Chun Chen and Pei-Fang Wu and Sung-Hsin Kuo and Chien-Jen Chen and Yen-Shen Lu and Ann-Lii Cheng; 林志弘;楊志新;陳偉武;郭文宏;盧彥伸;林璟宏;陳怡君;郭冠廷;郭頌鑫;吳佩芳;鄭安理;黃俊升;張端瑩;李日翔;林季宏; 林志弘;楊志新;陳偉武;郭文宏;盧彥伸;林璟宏;陳怡君;郭冠廷;郭頌鑫;吳佩芳;鄭安理;黃俊升;張端瑩;李日翔;林季宏; Lin, Ching-Hung; Lin, Ching-Hung; CHIUN-SHENG HUANG; Sung-Hsin Kuo; Shen, Chen-Yang; Chiang, I-Ni; CHING-HUNG LIN; Lee, Jih-Hsiang; Lee, Jih-Hsiang; Huang, Chiun-Sheng; KUAN-TING KUO; Huang, Chiun-Sheng; Yang, Chih-Hsin; ANN-LII CHENG; Yang, Chih-Hsin; Kuo, Wen-Hung; Kuo, Wen-Hung; Chang, Dwan-Ying; Chang, Dwan-Ying; Hsiung, Chia-Ni; Hsiung, Chia-Ni; Kuo, Kuan-Ting; Kuo, Kuan-Ting; Chen, Wei-Wu |
| 臺大學術典藏 |
2018-09-10T14:58:15Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
ANN-LII CHENG; Chang, Yih-Leong; Chang, Yih-Leong; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Yu-Lin;Liang, Yi-Hsin;Tsai, Jia-Huei;Liau, Jau-Yu;Liang, Jin-Tung;Lin, Been-Ren;Hung, Ji-Shiang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; LI-HUI TSENG; Lin, Yu-Lin; Liang, Yi-Hsin; Liang, Yi-Hsin; YIH-LEONG CHANG; Jin-Tung Liang; Chang, Jui-Hsing; Tsai, Jia-Huei; Liau, Jau-Yu; BEEN-REN LIN; JAU-YU LIAU; Liang, Jin-Tung; Lin, Been-Ren; LIANG-IN LIN; Lin, Been-Ren; Hung, Ji-Shiang; KUN-HUEI YEH; Ji-Shiang Hung; Lin, Liang-In; Tseng, Li-Hui; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅; 梁逸歆;林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;蔡佳惠;洪基翔;林本仁;廖肇裕;梁金銅 |
| 臺大學術典藏 |
2018-09-10T14:53:05Z |
Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases
|
Shao, Y.-Y. and Ho, M.-C. and Cheng, A.-L. and Hsu, C.-H.; Shao, Yu-Yun;Ho, Ming-Chih;Cheng, Ann-Lii;Hsu, Chih-Hung; 邵幼雲;鄭安理;徐志宏;何明志; 邵幼雲;鄭安理;徐志宏;何明志; Shao, Yu-Yun; Shao, Yu-Yun; MING-CHIH HO; CHIH-HUNG HSU; Ho, Ming-Chih; Ho, Ming-Chih; Cheng, Ann-Lii; Yu-Yun Shao; Hsu, Chih-Hung; ANN-LII CHENG; Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T14:52:03Z |
Inhibition of ZEB1 by miR-200 characterizes Helicobacter pylori-positive gastric diffuse large B-cell lymphoma with a less aggressive behavior
|
Wei-Ting Huang and Sung-Hsin Kuo and Ann-Lii Cheng and Chung-Wu Lin; Huang, Wei-Ting;Kuo, Sung-Hsin;Cheng, Ann-Lii;Lin, Chung-Wu; 林中梧;郭頌鑫;鄭安理; Huang, Wei-Ting; Sung-Hsin Kuo; CHUNG-WU LIN; Kuo, Sung-Hsin; Cheng, Ann-Lii; ANN-LII CHENG; Lin, Chung-Wu |
| 臺大學術典藏 |
2018-09-10T14:52:01Z |
Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study
|
Lin, Ching-Hung; Chuang, Po-Ya; Chiang, Chun-Ju; Lu, Yen-Shen; Cheng, Ann-Lii; Kuo, Wen-Hung; Huang, Chiun-Sheng; Lai, Mei-Shu; You, San-Lin; Tang, Chao-Hsiun; CHIUN-SHENG HUANG; Lin, Ching-Hung; ANN-LII CHENG; Chiang, Chun-Ju; Kuo, Wen-Hung |
| 臺大學術典藏 |
2018-09-10T14:51:53Z |
beta-Catenin (CTNNB1) Mutations Are Not Associated with Prognosis in Advanced Hepatocellular Carcinoma
|
高祥豐;邵幼雲;鄭安理;徐志宏;呂理駿;謝明書;李宜軒; Lu, Li-Chun; MIN-SHU HSIEH; CHIH-HUNG HSU; Shao, Yu-Yun; Lee, Yi-Hsuan; HSIANG-FONG KAO; Yu-Yun Shao; Hsieh, Min-Shu; ANN-LII CHENG; Hsiao, Chi-Huang; Lin, Hsiao-Hui; Kao, Hsiang-Fong; Ma, Yu-Yi; Yen, Feng-Chu; Cheng, Ann-Lii; Hsu, Chih-Hung; Lu, Li-Chun;Shao, Yu-Yun;Lee, Yi-Hsuan;Hsieh, Min-Shu;Hsiao, Chi-Huang;Lin, Hsiao-Hui;Kao, Hsiang-Fong;Ma, Yu-Yi;Yen, Feng-Chu;Cheng, Ann-Lii;Hsu, Chih-Hung; Lu, Li-Chun and Shao, Yu-Yun and Lee, Yi-Hsuan and Hsieh, Min-Shu and Hsiao, Chi-Huang and Lin, Hsiao-Hui and Kao, Hsiang-Fong and Ma, Yu-Yi and Yen, Feng-Chu and Cheng, Ann-Lii and Hsu, Chih-Hung |
| 臺大學術典藏 |
2018-09-10T14:50:59Z |
No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifen
|
Chen, T.W.-W.; Chen, H.-M.; Lin, C.-H.; Huang, C.-S.; Cheng, A.-L.; Lai, M.-S.; Lu, Y.-S.; CHIUN-SHENG HUANG; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T14:50:19Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, M.-L. and Yan, B.-S. and Lu, W.-C. and Chen, M.-H. and Yu, S.-L. and Yang, P.-C. and Cheng, A.-L.; Chen, Mei-Ling;Yan, Bo-Shiun;Lu, Wan-Chih;Chen, Mei-Huei;Yu, Sung-Liang;Yang, Pan-Chyr
Cheng, Ann-Lii; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; Hsu, F.M.; SUNG-LIANG YU; Chen, Mei-Ling; Chen, Mei-Ling; Yan, Bo-Shiun; BO-SHIUN YAN; Hsu, F.M.; ANN-LII CHENG; Lu, Wan-Chih; Chen, Mei-Huei; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr
Cheng, Ann-Lii; 楊泮池 |
| 臺大學術典藏 |
2018-09-10T14:50:09Z |
Phase ii multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer
|
Shen, Y.-C. and Li, C.-P. and Yen, C.-J. and Hsu, C. and Lin, Y.-L. and Lin, Z.-Z. and Chen, L.-T. and Su, W.-C. and Chao, Y. and Yeh, K.-H. and Cheng, A.-L.; Shen, Ying-Chun;Li, Chung-Pin;Yen, Chia-Jui;Hsu, Chiun;Lin, Yu-Lin;Lin, Zhong-Zhe;Chen, Li-Tzong;Su, Wu-Chou;Chao, Yee;Yeh, Kun-Huei;Cheng, Ann-Lii; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; 林宗哲;林育麟;鄭安理;許駿;葉坤輝; KUN-HUEI YEH; Shen, Ying-Chun; Shen, Ying-Chun; Li, Chung-Pin; YU-LIN LIN; Li, Chung-Pin; Yen, Chia-Jui; ANN-LII CHENG; Yen, Chia-Jui; Hsu, Chiun; Lin, Yu-Lin; Lin, Yu-Lin; Lin, Zhong-Zhe; Lin, Zhong-Zhe; Chen, Li-Tzong; Su, Wu-Chou; Chao, Yee; Yeh, Kun-Huei; Yeh, Kun-Huei; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:52:42Z |
Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-κb is associated with a poor prognosis of pancreatic cancer
|
Yang, S.-H. and Hsu, C.-H. and Lee, J.-C. and Tien, Y.-W. and Kuo, S.-H. and Cheng, A.-L.; CHIH-HUNG HSU; Sung-Hsin Kuo; JEN-CHIEH LEE; YU-WEN TIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:52:13Z |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: Complete response to combined intrathecal and systemic rituximab
|
Huang, H.-C. and Cheng, A.-L. and Lin, C.-W. and Kuo, S.-H.; Huang, Huai-Cheng;Cheng, Ann-Lii;Lin, Chung-Wu;Kuo, Sung-Hsin; 林中梧 ;郭頌鑫 ;鄭安理; HUAI-CHENG HUANG; Huang, Huai-Cheng; Sung-Hsin Kuo; Cheng, Ann-Lii; Lin, Chung-Wu; CHUNG-WU LIN; Kuo, Sung-Hsin; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:48:26Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Tseng, Li-Hui;Lin, Liang-In;Liang, Jin-Tung;Lin, Ben-Ren;Hung, Ji-Shiang;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Tseng, L.-H. and Lin, L.-I. and Liang, J.-T. and Lin, B.-R. and Hung, J.-S. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音;曾麗慧;張逸良;林育麟;鄭安理;葉坤輝;尤善琦;洪基翔;林本仁;廖肇裕;梁金銅; Lin, Yu-Lin; LI-HUI TSENG; Wang, Yu-Jen; YIH-LEONG CHANG; Huang, Chao-Yuan; Liau, Jau-Yu; Jin-Tung Liang; Hou, Wei-Hsien; Yu, Shan-Chi; Tseng, Li-Hui; JAU-YU LIAU; Wang, Chia-Chun; Lin, Liang-In; Lan, Keng-Hsueh; LIANG-IN LIN; Liang, Jin-Tung; Yu, Hong-Jen; KUN-HUEI YEH; Ji-Shiang Hung; Lin, Ben-Ren; Lai, Ming-Kuen; Hung, Ji-Shiang; YU-LIN LIN; Liu, Shihh-Ping; Pu, Yeong-Shau; Chang, Yih-Leong; ANN-LII CHENG; Cheng, Jason Chia-Hsien; Yeh, Kun-Huei; Cheng, Ann-Lii; 蒲永孝; 余宏政; 成佳憲; 王嘉檇; 賴明坤; 黃昭淵; 劉詩彬; 藍耿學 |
| 臺大學術典藏 |
2018-09-10T09:42:02Z |
Erratum: Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression (Gastric Cancer (2012) 15(265-280) DOI 10.1007/s10120-011- 0106-5)
|
Hsu, C.;Shen, Y.-C.;Cheng, C.-C.;Cheng, A.-L.;Hu, F.-C.;Yeh, K.-H.; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:41:59Z |
No evidence of IGH-MALT1-translocation in the Ma-1 cell line-A reply
|
Kuo, S.-H. and Weng, W.-H. and Yeh, K.-H. and Chen, L.-T. and Cheng, A.-L.; Sung-Hsin Kuo; KUN-HUEI YEH; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:41:58Z |
Beware imposters: MA-1, a novel MALT lymphoma cell line, is misidentified and corresponds to Pfeiffer, a diffuse large B-cell lymphoma cell line-A reply: Despite the same 8-code STR, MA-1 and Pfeiffer are cytogenetically diverse
|
Sung-Hsin Kuo and Hui-Jen Tsai and Wen-Hui Weng and Chi-Cheng Li and Kun-Huei Yeh and Li-Tzong Chen and Ann-Lii Cheng; Kuo, Sung-Hsin;Tsai, Hui-Jen;Weng, Wen-Hui;Li, Chi-Cheng;Yeh, Kun-Huei;Chen, Li-Tzong;Cheng, Ann-Lii; 郭頌鑫;鄭安理;葉坤輝; Kuo, Sung-Hsin; Sung-Hsin Kuo; Tsai, Hui-Jen; KUN-HUEI YEH; Weng, Wen-Hui; ANN-LII CHENG; Li, Chi-Cheng; Yeh, Kun-Huei; Chen, Li-Tzong; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclines
|
Chen, Wei-Wu;Chang, Dwan-Ying;Huang, Shu-Min;Lin, Ching-Hung;Hsu, Chun;Lin, Ming-Hwai;Huang, Chiun-Shen;Lu, Yen-Shen;Cheng, Ann-Lii; Chen, Wei-Wu; Chang, Dwan-Ying; Huang, Shu-Min; Lin, Ching-Hung; Hsu, Chun; Lin, Ming-Hwai; Huang, Chiun-Shen; Lu, Yen-Shen; Cheng, Ann-Lii; CHING-HUNG LIN; ANN-LII CHENG; Hsu, Chun; ���T�� |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
CYP19 genetic polymorphism haplotype aasa is associated with a poor prognosis in premenopausal women with lymph node-negative, hormone receptor-positive breast cancer
|
Kuo, Sung-Hsin; Yang, Shi-Yi; Lien, Huang-Chun; Lo, Chiao; Lin, Ching-Hung; Lu, Yen-Sen; Cheng, Ann-Lii; Chang, King-Jeng; Huang, Chiun-Sheng; Kuo, Sung-Hsin; CHIUN-SHENG HUANG; Sung-Hsin Kuo; Lien, Huang-Chun; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
Clinical significance of ESR1 gene copy number changes in breast cancer as measured by fluorescence in situ hybridisation
|
Lin, Ching-Hung;Liu, Jacqueline M.;Lu, Yen-Shen;Lan, Chieh;Lee, Wei-Chung;Kuo, Kuan-Ting;Wang, Chung-Chieh;Chang, Dwan-Ying;Huang, Chiun-Sheng;Cheng, Ann-Lii; Lin, Ching-Hung;Liu, Jacqueline M.;Lu, Yen-Shen;Lan, Chieh;Lee, Wei-Chung;Kuo, Kuan-Ting;Wang, Chung-Chieh;Chang, Dwan-Ying;Huang, Chiun-Sheng;Cheng, Ann-Lii; Wang, Chung-Chieh; Chang, Dwan-Ying; Huang, Chiun-Sheng; Cheng, Ann-Lii; 盧彥伸 ;郭冠廷 ;王中傑 ;鄭安理 ;黃俊升 ;張端瑩 ;林璟宏; CHIUN-SHENG HUANG; Lin, Ching-Hung; Liu, Jacqueline M.; CHING-HUNG LIN; KUAN-TING KUO; Lu, Yen-Shen; Kuo, Kuan-Ting; ANN-LII CHENG; Lan, Chieh; Lee, Wei-Chung |
| 臺大學術典藏 |
2018-09-10T09:41:56Z |
Bevacizumab might potentiate the chemotherapeutic effect in breast cancer patients with leptomeningeal carcinomatosis
|
Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen;林季宏; Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen; Chen, I-Chun;Lin, Ching-Hung;Jan, I-Shiow;Cheng, Ann-Lii;Lu, Yen-Shen; 盧彥伸;林璟宏;詹一秀;陳怡君;鄭安理;林季宏; I-SHIOW JAN; Kao, Jia-Horng; Chen, I-Chun; Lin, Ching-Hung; CHING-HUNG LIN; Lin, Ching-Hung; ANN-LII CHENG; Jan, I-Shiow; Jan, I-Shiow; Cheng, Ann-Lii; Cheng, Ann-Lii; Lu, Yen-Shen; Lu, Yen-Shen; 高嘉宏 |
| 臺大學術典藏 |
2018-09-10T09:39:54Z |
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
|
Chen, K.-F.;Chen, H.-L.;Shiau, C.-W.;Liu, C.-Y.;Chu, P.-Y.;Tai, W.-T.;Ichikawa, K.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Cancerous Inhibitor of Protein Phosphatase 2A Mediates Bortezomib-Induced Autophagy in Hepatocellular Carcinoma Independent of Proteasome
|
Yu, H.-C.;Hou, D.-R.;Liu, C.-Y.;Lin, C.-S.;Shiau, C.-W.;Cheng, A.-L.;Chen, K.-F.; Yu, H.-C.; Hou, D.-R.; Liu, C.-Y.; Lin, C.-S.; Shiau, C.-W.; Cheng, A.-L.; Chen, K.-F.; CHEN-SI LIN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:39:53Z |
Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinoma
|
Yu, H.-C.;Chen, H.-J.;Chang, Y.-L.;Liu, C.-Y.;Shiau, C.-W.;Cheng, A.-L.;Chen, K.-F.; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T09:22:43Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Lin, Yu-Lin;Liau, Jau-Yu;Yu, Shan-Chi;Ou, Da-Liang;Lin, Liang-In;Tseng, Li-Hui;Chang, Yih-Leong;Yeh, Kun-Huei;Cheng, Ann-Lii; Lin, Y.-L. and Liau, J.-Y. and Yu, S.-C. and Ou, D.-L. and Lin, L.-I. and Tseng, L.-H. and Chang, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; 林亮音 ;曾麗慧 ;張逸良 ;林育麟 ;鄭安理 ;葉坤輝 ;歐大諒 ;尤善琦 ;廖肇裕; Lin, Yu-Lin; LI-HUI TSENG; Lin, Yu-Lin; Liau, Jau-Yu; YIH-LEONG CHANG; JAU-YU LIAU; Yu, Shan-Chi; Ou, Da-Liang; DA-LIANG OU; Ou, Da-Liang; LIANG-IN LIN; Lin, Liang-In; Lin, Liang-In; Tseng, Li-Hui; KUN-HUEI YEH; Tseng, Li-Hui; Chang, Yih-Leong; YU-LIN LIN; Yeh, Kun-Huei; ANN-LII CHENG; Yeh, Kun-Huei; Cheng, Ann-Lii; Cheng, Ann-Lii; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:16:02Z |
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: A meta-analysis and meta-regression
|
Hsu, Chiun;Shen, Ying-Chun;Cheng, Chia-Chi;Cheng, Ann-Lii;Hu, Fu-Chang;Yeh, Kun-Huei; Hsu, C. and Shen, Y.-C. and Cheng, C.-C. and Cheng, A.-L. and Hu, F.-C. and Yeh, K.-H.; 鄭安理 ;許駿 ;葉坤輝; Hsu, Chiun; KUN-HUEI YEH; Hsu, Chiun; Shen, Ying-Chun; ANN-LII CHENG; Shen, Ying-Chun; Cheng, Chia-Chi; Cheng, Chia-Chi; Cheng, Ann-Lii; Hu, Fu-Chang; Hu, Fu-Chang; Yeh, Kun-Huei; Yeh, Kun-Huei |
| 臺大學術典藏 |
2018-09-10T09:15:58Z |
The emerging epidemic of estrogen-related cancers in young women in a developing Asian country
|
CHIUN-SHENG HUANG; Lin, Ching-Hung; Chen, Yong-Chen; WEN-FANG CHENG; CHING-HUNG LIN; CHIANG,CHUN-JU; KUAN-TING KUO; Lu, Yen-Shen; ANN-LII CHENG; Kuo, Kuan-Ting; Huang, Chiun-Sheng; Cheng, Wen-Fang; Lai, Mei-Shu; You, San-Lin; Cheng, Ann-Lii; 鄭文芳 ;盧彥伸 ;賴美淑 ;郭冠廷 ;鄭安理 ;黃俊升 ;林璟宏; Lin, Ching-Hung;Chen, Yong-Chen;Chiang, Chun-Ju;Lu, Yen-Shen;Kuo, Kuan-Ting;Huang, Chiun-Sheng;Cheng, Wen-Fang;Lai, Mei-Shu;You, San-Lin;Cheng, Ann-Lii; Lin, Ching-Hung;Chen, Yong-Chen;Chiang, Chun-Ju;Lu, Yen-Shen;Kuo, Kuan-Ting;Huang, Chiun-Sheng;Cheng, Wen-Fang;Lai, Mei-Shu;You, San-Lin;Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T09:15:01Z |
Vandetanib in patients with inoperable hepatocellular carcinoma: A phase II, randomized, double-blind, placebo-controlled study
|
Hsu, C. and Yang, T.-S. and Huo, T.-I. and Hsieh, R.-K. and Yu, C.-W. and Hwang, W.-S. and Hsieh, T.-Y. and Huang, W.-T. and Chao, Y. and Meng, R. and Cheng, A.-L.; Hsu, Chiun;Yang, Tsai-Sheng;Huo, Teh-Ia;Hsieh, Ruey-Kuen;Yu, Chih-Wei;Hwang, Wei-Shou;Hsieh, Tsai-Yuan;Huang, Wen-Tsung;Chao, Yee;Meng, Robin;Cheng, Ann-Lii; 鄭安理 ;許駿 ;游治維; CHIH-WEI YU; Hsu, Chiun; ANN-LII CHENG; Yang, Tsai-Sheng; Huo, Teh-Ia; Hsieh, Ruey-Kuen; Yu, Chih-Wei; Hwang, Wei-Shou; Hsieh, Tsai-Yuan; Huang, Wen-Tsung; Chao, Yee; Meng, Robin; Cheng, Ann-Lii |
| 臺大學術典藏 |
2018-09-10T08:41:21Z |
Sorafenib derivatives induce apoptosis through inhibition of STAT3 independent of Raf
|
Chen, K.-F.;Tai, W.-T.;Huang, J.-W.;Hsu, C.-Y.;Chen, W.-L.;Cheng, A.-L.;Chen, P.-J.;Shiau, C.-W.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:33:58Z |
Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials
|
Yang, S.-H. and Kuo, Y.-H. and Tien, Y.-W. and Hsu, C. and Hsu, C.-H. and Kuo, S.-H. and Cheng, A.-L.; CHIH-HUNG HSU; Sung-Hsin Kuo; YU-WEN TIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:33:58Z |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'Ang, H.-J. and Lin, Y.-L. and Wang, H.-P. and Chiu, Y.-F. and Chang, M.-C. and Hsu, C.-H. and Tien, Y.-W. and Chen, J.-S. and Hsieh, R.-K. and Lin, P.-W. and Shan, Y.-S. and Cheng, A.-L. and Chang, J.-Y. and Whang-Peng, J. and Hwang, T.-L. and Chen, L.-T.; CHIH-HUNG HSU; YU-WEN TIEN; YU-LIN LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:32:52Z |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, J.-S. and Chao, Y. and Hsieh, R.-K. and Cheng, A.-L. and Chen, P.-M. and Chiou, T.-J. and Chao, T.-Y. and Yeh, K.-H. and Chen, L.-T. and Whang-Peng, J.; 陳仁熙;趙毅;鄭安理;陳博明;邱宗傑;趙祖怡;葉坤輝;陳立宗;彭汪嘉康; CHEN, JEN-SHI;CHAO, YEE;CHENG, ANN-LII;CHEN, PO-MIN;CHIOU, TZEON-JYE;CHAO, TSU-YI;YEH, KUN-HUEI;CHEN, LI-TZONG;WHANG-PENG, JACQUELINE; KUN-HUEI YEH; ANN-LII CHENG; CHEN, JEN-SHI; CHAO, YEE; CHENG, ANN-LII; CHEN, PO-MIN; CHIOU, TZEON-JYE; CHAO, TSU-YI; YEH, KUN-HUEI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE |
| 臺大學術典藏 |
2018-09-10T08:32:44Z |
Lack of efficacy to systemic chemotherapy for treatment of metaplastic carcinoma of the breast in the modern era
|
Chen, I.C.; Lin, C.H.; Huang, C.S.; Lien, H.C.; Hsu, C.; Kuo, W.H.; Lu, Y.S.; Cheng, A.L.; CHIUN-SHENG HUANG; CHING-HUNG LIN; HUANG-CHUN LIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:31:21Z |
Phase I, pharmacokinetic, and bone marrow drug-level studies of trimonthly 48-h infusion of high-dose 5-fluorouracil and leucovorin in patients with metastatic colorectal cancers
|
Ho, Y.-F. Lu, W.-C. Chen, R.R.-L. Cheng, A.-L. Yeh, K.-H.; KUN-HUEI YEH; YUNN-FANG HO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:56Z |
T(11;18)(q21;q21) translocation as predictive marker for non-responsiveness to salvage thalidomide therapy in patients with marginal zone B-cell lymphoma with gastric involvement
|
Kuo, S.-H. and Cheng, A.-L. and Lin, C.-W. and Hsu, C.-H. and Wu, M.-S. and Yeh, K.-H. and Tzeng, Y.-S. and Chen, L.-T.; CHIH-HUNG HSU; Sung-Hsin Kuo; CHUNG-WU LIN; KUN-HUEI YEH; MING-SHIANG WU; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:12Z |
Recent advances in the treatment of metastatic colorectal cancer in Taiwan
|
Lin, Y.-L. and Yeh, K.-H. and Cheng, A.-L.; KUN-HUEI YEH; YU-LIN LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Bortezomib sensitizes HCC cells to CS-1008, an antihuman death receptor 5 antibody, through the inhibition of CIP2A
|
Chen, K.-F. Yu, H.-C. Liu, C.-Y. Chen, H.-J. Chen, Y.-C. Hou, D.-R. Chen, P.-J. Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:30:05Z |
Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:21:44Z |
Fractionated evaluation of immunohistochemical hormone receptor expression enhances prognostic prediction in breast cancer patients treated with tamoxifen as adjuvant therapy
|
Lin, C.-H. and Lien, H.-C. and Hu, F.-C. and Lu, Y.-S. and Kuo, S.-H. and Wu, L.-C. and You, S.-L. and Cheng, A.-L. and Chang, K.-J. and Huang, C.-S.; CHIUN-SHENG HUANG; Sung-Hsin Kuo; CHING-HUNG LIN; HUANG-CHUN LIEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:15:22Z |
Predictive and prognostic values of tau and ERCC1 in advanced breast cancer patients treated with paclitaxel and cisplatin
|
Shao, Y.-Y. and Kuo, K.-T. and Hu, F.-C. and Lu, Y.-S. and Huang, C.-S. and Liau, J.-Y. and Lee, W.-C. and Hsu, C. and Kuo, W.-H. and Chang, K.-J. and Lin, C.-H. and Cheng, A.-L.; CHIUN-SHENG HUANG; Yu-Yun Shao; JAU-YU LIAU; CHING-HUNG LIN; KUAN-TING KUO; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:48Z |
Asian pacific association for the study of the liver consensus recommendations on hepatocellular carcinoma
|
Omata, M.;Lesmana, L.A.;Tateishi, R.;Chen, P.-J.;Lin, S.-M.;Yoshida, H.;Kudo, M.;Lee, J.M.;Choi, B.I.;Poon, R.T.P.;Shiina, S.;Cheng, A.L.;Jia, J.-D.;Obi, S.;Han, K.H.;Jafri, W.;Chow, P.;Lim, S.G.;Chawla, Y.K.;Budihusodo, U.;Gani, R.A.;Lesmana, C.R.;Putranto, T.A.;Liaw, Y.F.;Sarin, S.K.; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:13:43Z |
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation
|
Chen, K.-F.;Yu, H.-C.;Liu, T.-H.;Lee, S.-S.;Chen, P.-J.;Cheng, A.-L.; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG; SHOEI-SHENG LEE |
| 臺大學術典藏 |
2018-09-10T08:06:38Z |
Unusual presentation of multiple pathologic bone fractures in a patient with gastric mucosa-associated lymphoid tissue lymphoma
|
Kuo, S.-H. and Yen, R.-F. and Lin, C.-W. and Chen, L.-T. and Tien, H.F. and Cheng, A.-L.; HWEI-FANG TIEN; Sung-Hsin Kuo; RUOH-FANG YEN; CHUNG-WU LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:37Z |
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cells
|
Weng, Y.-I.;Hsu, P.-Y.;Liyanarachchi, S.;Liu, J.;Deatherage, D.E.;Huang, Y.-W.;Zuo, T.;Rodriguez, B.;Lin, C.-H.;Cheng, A.-L.;Huang, T.H.-M.; CHING-HUNG LIN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:06:36Z |
O6-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers
|
Wu, Pei-Fang;Kuo, Kuan-Ting;Kuo, Lu-Ting;Lin, Yi-Ting;Lee, Wei-Chung;Lu, Yen-Shen;Yang, Chih-Hsin;Wu, Ruey-Meei;Tu, Yong-Kwang;Tasi, Jui-Chang;Tseng, Ham-Min;Tseng, Sheng-Hong;Cheng, Ann-Lii;Lin, Ching-Hung; Wu, Pei-Fang; Ruey-Meei Wu; Lu-Ting Kuo; Kuo, Kuan-Ting; Kuo, Lu-Ting; Yong-Kwang Tu; Lin, Yi-Ting; CHING-HUNG LIN; KUAN-TING KUO; Lee, Wei-Chung; ANN-LII CHENG; Lu, Yen-Shen; Yang, Chih-Hsin; Wu, Ruey-Meei; Tu, Yong-Kwang; Tasi, Jui-Chang; Tseng, Ham-Min; Tseng, Sheng-Hong; Cheng, Ann-Lii; Lin, Ching-Hung |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T08:03:10Z |
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCC
|
Lin, Z.-Z. and Jeng, Y.-M. and Hu, F.-C. and Pan, H.-W. and Tsao, H.-W. and Lai, P. and Lee, P. and Cheng, A.-L. and Hsu, H.-C.; PO-HUANG LEE; YUNG-MING JENG; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:37:25Z |
Synergistic Effect of Radiation and Interleukin-6 on Hepatitis B Virus Reactivation in Liver Through STAT3 Signaling Pathway
|
Chou, C.H. and Chen, P.-J. and Jeng, Y.-M. and Cheng, A.-L. and Huang, L.-R. and Cheng, J.C.-H.; YUNG-MING JENG; PEI-JER CHEN; ANN-LII CHENG |
| 臺大學術典藏 |
2018-09-10T07:26:16Z |
Phase II study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of 5-fluorouracil/leucovorin (GOFL) in advanced pancreatic cancer
|
Ch'ang, H.-J. and Huang, C.-L. and Wang, H.-P. and Shiah, H.-S. and Chang, M.-C. and Jan, C.-M. and Chen, J.-S. and Tien, Y.-W. and Hwang, T.-L. and Lin, J.-T. and Cheng, A.-L. and Whang-Peng, J. and Chen, L.-T.; YU-WEN TIEN; ANN-LII CHENG |
顯示項目 581-630 / 690 (共14頁)
<< < 5 6 7 8 9 10 11 12 13 14 > >>
每頁顯示[10|25|50]項目
|
